Current News

Contact | Print version | PDF version | Send article | RSS-Feed

IBA Announces Expansion of Collaboration with MorphoSys's AbD Serotec

06 Dec 2006 - IBA GmbH announced the signing of a second license agreement with MorphoSys AG regarding recombinant antibody purification using IBA's proprietary Strep-tag® technology. The original research license agreement dating back to the year 2000 has now been complemented with a second license agreement rendering the commercial use of IBA's Strep-tag patent rights for custom service purification of antibodies by AbD Serotec - a business unit of MorphoSys AG.
 
The license granted by IBA is worldwide and non-exclusive. According to the company, recent IBA developments in the Strep-tag field had proven to be advantageous compared to other tag-systems for automated batch purification of recombinant antibodies. Financial details of the license agreement were not disclosed.